Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary Levosimendan in Cardiac Surgery
NCT01500785Phase 4Terminated
- Sponsor
- Tampere University Hospital
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Myocardial stunning comparing Levosimendan with Placebo (2 arms). Primary endpoint: Change in Cardiac Output. Started Jun 2018; status: terminated.
02
Drugs
levosimendan
03
Conditions
Myocardial stunning
Beyond the preview
Go deeper on NCT01500785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01500785.